Who are the key vendors in the Global Ophthalmology Devices Market?

The competitive environment of the Global Ophthalmology Devices Market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Detailed information includes jurisdiction over company design, company finances, earnings, market potential, investment in research and development, market innovation, global presence, manufacturing locations and manufacturing facilities, production capacity, company strengths and weaknesses, product launches, product expansion and expansion, and applications. The above data points provided only relate to the perspective of companies in the global market. Key companies operating in this market include Alcon, Regeneron Pharmaceuticals Inc., Johnson & Johnson, Inc., Novartis AG, Bausch & Lomb Incorporated, HOYA Corporation. 'Novartis AG', 'Carl Zeiss Meditec AG', 'Essilor International S.A.', 'HAAG-Streit Holding AG', 'Johnson & Johnson', 'Nidek Co., Ltd.', 'Topcon Corporation', 'Valeant Pharmaceuticals International, Inc.', 'Ziemer Ophthalmic Systems AG', 'Hoya Corporation', 'Alcon Vision LLC', 'Bausch & Lomb Incorporated', 'Alcon', 'Regeneron Pharmaceuticals Inc.', 'Bausch & Lomb Incorporated', 'HOYA Corporation', 'The Cooper Companies Inc.', 'Santen Pharmaceutical Co., Ltd.'.

What is the key driver of Global Ophthalmology Devices Market?

Eye infections are a major cause of severe eye pain. Eye pain is accompanied by symptoms such as dry eyes, burning and pain. This can be caused by many factors including foreign irritants, infection or trauma. Eyelashes or dirt particles, smoke, dust or some harsh makeup products are the most common causes of irritated, red and watery eyes. With increasing pharmaceutical industry and pollution worldwide, the prevalence of eye pain continues to show an increase. Chemical burns and flash burns cause severe eye pain and severity due to irritation of the cornea. Style and blepharitis are common causes of eye pain as they increase the sensitivity of the eye and oil glands surrounding the area.

What is the key market trend for Global Ophthalmology Devices Market?

The introduction of new equipment, accessories, contact lenses, etc. has increased the demand for these devices for healthcare professionals and patients. For example, micro-invasive glaucoma (MIGs) cosmetic surgery in new has been one of the fastest growing technologies for the treatment of mild to moderate glaucoma. Market players are focusing on the innovative micro-invasive cataract surgical implants that will drive the growth of the global ophthalmic devices market during the forecast period.

Which region accounted for the largest share in Global Ophthalmology Devices Market?

North America controlled 43% of the market by 2022. The major factors influencing the market were the continuous expansion of the aging population and chronic eye problems due to high stress and lifestyle. The negative course of diabetic retinopathy is common. The ophthalmic device market in this region is expected to be driven by additional reimbursements for ophthalmology treatments and stringent regulations designed to ensure patient safety. North America, especially the United States, holds a dominant position in the global market. The industry benefits from well-established healthcare infrastructure, higher healthcare costs and a higher patient population with various eye diseases.

Ophthalmology Devices Market Size, Share, Growth Analysis, By Product(Surgical & Vision Care), By Application(Cataract and Glaucoma), By End-user(Hospitals, Ophthalmic Clinics, Eye Clinics and Others), By Region - Industry Forecast 2025-2032

Report ID: SQMIG35A2872 | Region: Global | Published Date: October, 2024
Pages: 190 | Tables: 86 | Figures: 74

Ophthalmology Devices Market News

In August 2023, Johnson & Johnson Vision presented its Elita laser correction device in the U.S. launch. This platform offers a revolutionary way to correct short-sightedness through a minimally invasive laser-assisted lens removal procedure.
In July 2023, Alkem Laboratories announced its entry into the Ophthalmology field with the launch of a massive portfolio of quality and affordable eye care products. This launch of Alkem’s ophthalmic product confirms that patients in India have access to quality eye care formulations at an affordable price.
In October 2022, Remidio launched Instaref R20, a lightweight and portable ophthalmic auto refractometer at the American Academy of Ophthalmology in Chicago.

Ophthalmology Devices Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Ophthalmology Devices Market size was valued at USD 28.33 Billion in 2022 and is poised to grow from USD 29.52 Billion in 2023 to USD 36.26 Billion by 2031, growing at a CAGR of 4.2% in the forecast period (2024-2031).

The ophthalmology devices market is highly competitive, with key players seeking to innovate and expand their offerings to meet the growing demand for access to advanced diagnostic, surgical, and vision care solutions. A notable example is the partnership between Carl Zeiss Meditech and Verana Health, which aims to advance data-driven solutions for ophthalmology. This collaboration uses Verana Health's clinical database and Carl Zeiss Meditech's diagnostic tools and surgical expertise to perform predictive analytics and improve patient outcomes. 'Novartis AG', 'Carl Zeiss Meditec AG', 'Essilor International S.A.', 'HAAG-Streit Holding AG', 'Johnson & Johnson', 'Nidek Co., Ltd.', 'Topcon Corporation', 'Valeant Pharmaceuticals International, Inc.', 'Ziemer Ophthalmic Systems AG', 'Hoya Corporation', 'Alcon Vision LLC', 'Bausch & Lomb Incorporated', 'Alcon', 'Regeneron Pharmaceuticals Inc.', 'Bausch & Lomb Incorporated', 'HOYA Corporation', 'The Cooper Companies Inc.', 'Santen Pharmaceutical Co., Ltd.'

Growing Prevalence of Ophthalmic Disorders: The rise in the prevalence of glaucoma and age-related macular degeneration (AMD) is a significant driver for the ophthalmology devices market. Both conditions are becoming increasingly common due to the global aging population. Glaucoma, a group of eye conditions that damage the optic nerve and can lead to vision loss, is particularly prevalent among older adults. Similarly, age-related macular degeneration, a leading cause of vision loss in people over 50, affects the central part of the retina, causing severe impairment in vision. As these conditions become more widespread, there is a growing demand for advanced diagnostic and therapeutic devices. This ophthalmology devices market trend is driving innovation and investment in ophthalmology technologies, including imaging systems, laser devices, and surgical instruments.

As per the ophthalmology devices market analysis, North America held the largest share in 2023. A high population of older adults and rising prevalence of chronic eye conditions resulting from factors, such as high stress and unhealthy lifestyles; ultimately leading to diabetic retinopathy, are considered high impact rendering drivers for the market. In addition, the incorporation of new reimbursement models for ophthalmologic treatment and a stringent regulatory framework aimed at patients’ safety, is expected to fuel product demand in this region. The U.S. possesses a well-developed healthcare system with leading academic institutions and research facilities. This encourages innovations in ophthalmic devices in terms of minimally invasive surgical techniques, advanced diagnostic instruments, and personalized medicine approaches, thereby propelling growth for the market. The U.S. spends significantly on healthcare compared to other developed countries, with total healthcare spending projected to reach $4.8 trillion by 2030. This translates into increased funding for specialized therapies and devices, including eye care.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Ophthalmology Devices Market Size, Share, Growth Analysis, By Product(Surgical & Vision Care), By Application(Cataract and Glaucoma), By End-user(Hospitals, Ophthalmic Clinics, Eye Clinics and Others), By Region - Industry Forecast 2025-2032

Ophthalmology Devices Market News

Ophthalmology Devices Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Ophthalmology Devices Market?

Who are the key vendors in the Ophthalmology Devices Market?

What is the key driver of Ophthalmology Devices Market?

What is the key market trend for Ophthalmology Devices Market?

Which region accounted for the largest share in Ophthalmology Devices Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300